Independent advisory · Medical isotopes & radiopharmaceuticals

Commercial and supply chain expertise for medical isotopes and radiopharmaceuticals

Nuclidx advises isotope producers, radiopharmaceutical companies and investors on commercial strategy, market intelligence, isotope sourcing and supply agreements.

Built on more than ten years in nuclear medicine, including senior roles in the Novartis/AAA radioligand therapy supply chain.

Discuss your question About Serge Elemans

Who you work with

Senior expertise, independent perspective

I’m Serge Elemans, founder of Nuclidx. I started my career in nuclear medicine at IDB Holland and Advanced Accelerator Applications, and later held senior international roles in the radioligand therapy organisation at Novartis, across commercial, operational and supply-chain functions.

Today I advise companies and investors independently. You work with me directly: the person who scopes your question is the person who does the work.

10+ yearsin nuclear medicine and medical isotopes
Novartis / AAAradioligand therapy supply chain
Independentdirect senior involvement, no layers

“Serge brings a rare combination of strategic clarity and technical understanding to the table.”

Sergio Cerdas, Global Head of Radioligand Therapies (RLT) Technical Operations, Novartis Pharmaceuticals

More about my background →

Services

Strategic and commercial advisory for medical isotopes and radiopharmaceuticals

Senior advice on the commercial and strategic questions that shape growth in this sector, informed by hands-on operational experience across the isotope supply chain.

01

Commercial strategy & market intelligence

For leadership teams and investors making decisions in a market where supply, demand and competition shift quickly.
- Market assessments and supply–demand dynamics
- Competitive landscapes and market entry
- Pricing strategy
- Commercial due diligence for investors
02

Business development & strategic partnerships

For companies growing through the right customers, partners and agreements.
- Identifying and prioritising commercial opportunities
- Evaluating partners and strategic transactions
- Go-to-market strategy
- Structuring and negotiating supply and commercial agreements
03

Supply-chain strategy & isotope sourcing

For producers, radiopharmaceutical companies and investors who need supply that holds up as programmes scale.
- Strategic supply-chain assessments
- Isotope availability and capacity outlooks
- Supply security and diversification
- Supplier evaluation and long-term sourcing strategy

How clients work with Nuclidx

Project advisory

A defined question and deliverable, such as a market assessment, a partnering strategy, a supply-chain review or commercial due diligence.

Senior advisor

Ongoing counsel for CEOs, commercial leaders and boards on strategic and commercial decisions, including executive briefings.

Interim leadership

Interim commercial or business development leadership when a key role is vacant or a growth phase needs senior capacity.

Typical clients

CEOs, CCOs, business development and corporate strategy teams at isotope producers and radiopharmaceutical companies, and private equity and venture investors evaluating the sector.

Isotope expertise

Commercial and technical depth across the main therapeutic and diagnostic isotopes.

Lu-177
Ac-225
Tb-161
Ga-68
Mo-99 / Tc-99m
Stable isotopes

Services in more detail → Discuss your question →

New! Monthly Membership plans

Gain the Strategic Edge in Radiopharmaceuticals

Nuclidx monthly memberships are designed for decision-makers in theranostics, radiopharma, and isotope supply. Whether you’re a biotech BD lead, pharma strategist, or an emerging isotope supplier, this is your unfair advantage.

Stay ahead of shifting markets, evolving partnerships, and production bottlenecks, with curated insights that save you time and sharpen your decisions.

- Monthly Executive Briefings on what’s happening in the market with expert commentary
- Deep Dive Market Reports each quarter
- Strategic Landscape Maps of key players and suppliers
- (Gold only) Up to one 30-minute 1 : 1 strategy call every 2 months — based on your needs
- Insights you won’t find on Google or in public databases